Competitive Research Grant: How does lebrikizumab impact post-inflammatory dyspigmentation as measured by the PDCA-Derm™ scale in patients with moderate to severe atopic dermatitis?- marychames@gmail.com Competitive Research Grant: How does lebrikizumab impact post-inflammatory dyspigmentation as measured by the PDCA-Derm™ scale in patients with moderate to severe atopic dermatitis?- Read More »
Lebrikizumab – Inflammatory/Dermatology Research Grants Guloona I Lebrikizumab – Inflammatory/Dermatology Research Grants Read More »
Investigator Initiated Trial: Atopic Dermatitis Guloona I Investigator Initiated Trial: Atopic Dermatitis Read More »